KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,740,509 | -28.0% | 365,134 | -7.7% | 0.02% | -22.7% |
| Q2 2023 | $85,776,535 | +41.8% | 395,557 | +18.8% | 0.02% | +29.4% |
| Q1 2023 | $60,477,947 | +1.4% | 332,955 | +9.7% | 0.02% | 0.0% |
| Q4 2022 | $59,637,949 | -13.6% | 303,501 | -1.1% | 0.02% | -22.7% |
| Q3 2022 | $69,029,000 | +4083.6% | 306,895 | +2253.3% | 0.02% | – |
| Q2 2022 | $1,650,000 | +7.0% | 13,041 | +7.2% | 0.00% | – |
| Q1 2022 | $1,542,000 | +0.6% | 12,163 | +4.0% | 0.00% | – |
| Q4 2021 | $1,533,000 | -0.5% | 11,696 | -7.1% | 0.00% | – |
| Q3 2021 | $1,540,000 | +22.9% | 12,585 | +14.5% | 0.00% | – |
| Q2 2021 | $1,253,000 | +73.3% | 10,990 | +82.8% | 0.00% | – |
| Q1 2021 | $723,000 | +120.4% | 6,012 | +86.0% | 0.00% | – |
| Q4 2020 | $328,000 | -97.4% | 3,232 | -97.1% | 0.00% | -100.0% |
| Q2 2020 | $12,413,000 | – | 111,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |